PDUFA Action Date for Natpara(R) BLA Extended Three Months to January 24, 2015
1 minutes ago - BusinessWire via Dow Jones News
BEDMINSTER, N.J.--(BUSINESS WIRE)--October 23, 2014-- NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today reported that the U.S. Food and Drug Administration (FDA) has extended the company's Prescription Drug User Fee Act (PDUFA) action date for its Natpara Biologics License Application (BLA) by three months from October 24, 2014 to January 24, 2015. The FDA extended t...